ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Navigating Wearable Integration: Key Operational Considerations

  Explore wearable devices' transformative potential and innovative capabilities for data collection, patient monitoring, and endpoint measurement.

• PEAK Matrix® For Decentralized Clinical Trial Platforms Provider 2023

  Explore how technological advancements, innovative business models, increased wearables support, FDA’s push to the industry to adopt DCTs, and a holistic approach to clinical trials have proliferated the DCT landscape.

• What AI Replaces In Phase 2/3 Data Management

  Explore how clinical teams are moving beyond AI hype to implement grounded strategies for automated edit checks, risk-based query management, and the regulatory frameworks needed for oversight.

• 5 Projections For 2026: Navigating The New Normal In Clinical Trials

  In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.

• Single-Arm Trials Use Real-World Evidence For Rare Disease Drug Development

  In rare disease product development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Gain insight into the regulatory considerations for single-arm trials.

• Strategies For More Accurate Clinical Trial Forecasting And Budgeting

  Explore some of the best strategies and practices to ensure clinical trial staff get approval for their budgets, with forecasts as accurate as possible.

• Customizing EDC Workflows For Specialty Pharma, Rare Disease Trials

  Rare disease and specialty pharma trials demand a level of flexibility with electronic data capture systems that can adapt dynamically without sacrificing data integrity.

• Data-Driven Physician Engagement For Ultra-Rare Diseases

  How can an effective partnership help you to utilize advanced data analytics to address the significant challenges of clinical trials centered around ultra-rare diseases?

• We Need Regulatory Clarity—Not Complexity In Clinical Trial Technology

  The current U.S. deregulatory momentum should not diminish compliance standards but instead serve as a call to streamline and modernize regulatory guidance.

• From Buzzword To Backbone: AI Reshaping Clinical Trial Operations

  For teams evaluating how to accelerate study startup without sacrificing rigor, this is a clear look at what AI-native trial technology makes possible now.